Abstract 4770: Anti-ROR1 monoclonal antibodies induce apoptosis in pancreatic cancer cells via the PI3-kinase/AKT/mTOR pathway
Amir Hossein Daneshmanesh(Karolinska University Hospital), Håkan Mellstedt(Karolinska University Hospital), Ali Moshfegh(Karolinska University Hospital), Anders Österborg(Karolinska University Hospital), Eva Mikaelsson(Karolinska University Hospital), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Abdul Salam Khan(Karolinska University Hospital)
Cited by 7
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
CAMPATH-1H monoclonal antibody in therapy for previously treated low-grade non-Hodgkin's lymphomas: a phase II multicenter study. European Study Group of CAMPATH-1H Treatment in Low-Grade Non-Hodgkin's Lymphoma.
|Journal of Clinical Oncology|1998|258
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202